Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · IEX Real-Time Price · USD
7.10
+0.10 (1.43%)
Jul 22, 2024, 9:51 AM EDT - Market open
Coya Therapeutics Employees
Coya Therapeutics had 8 employees as of December 31, 2023. The number of employees increased by 2 or 33.33% compared to the previous year.
Employees
8
Change (1Y)
2
Growth (1Y)
33.33%
Revenue / Employee
$766,131
Profits / Employee
-$1,287,911
Market Cap
108.37M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 8 | 2 | 33.33% |
Dec 31, 2022 | 6 | 0 | - |
Dec 31, 2021 | 6 | - | - |
Related Stocks
Company Name | Employees |
---|---|
FibroGen | 486 |
InterCure | 270 |
BrainsWay | 134 |
IO Biotech | 68 |
Regulus Therapeutics | 30 |
Zentek | 24 |
Eledon Pharmaceuticals | 20 |
COYA News
- 4 weeks ago - Coya Therapeutics Expands Sponsored Research Collaboration with Houston Methodist Research Institute Along with Funding from the Johnson Center for Cellular Therapeutics to Advance Regulatory T Cell Exosome Platform into the Clinic - Business Wire
- 5 weeks ago - Coya Therapeutics Announces Publication of ALS Study in Peer-Reviewed Journal Frontiers in Neurology - Business Wire
- 7 weeks ago - Coya Therapeutics Announces Acceptance of Peer-Reviewed Manuscript in the Medical Journal: Frontiers in Neurology - Business Wire
- 7 weeks ago - Coya Therapeutics Announces Inclusion in the MSCI USA Micro Cap Index - Business Wire
- 2 months ago - Coya Therapeutics Announces the Completion of a Controlled Phase 2 Study of Low Dose Interleukin-2 (LD IL-2) in Patients with Alzheimer's Disease - Business Wire
- 2 months ago - Coya Therapeutics Announces $5 Million Strategic Investment by the Alzheimer's Drug Discovery Foundation (ADDF) - Business Wire
- 2 months ago - Coya Therapeutics Provides a Corporate Update and Reports Unaudited First Quarter 2024 Financial Results - Business Wire
- 3 months ago - Coya Therapeutics Presents Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium - Business Wire